🇦🇪UAE
غرامات عدم الامتثال لتتبع تتمين
2 verified sources
Definition
Failure to serialize and track via Tatmeen results in non-compliant products being barred from UAE market, causing direct revenue loss from unsellable inventory and penalties from MoHAP.
Key Findings
- Financial Impact: AED 50,000+ per major violation (product rejection/audit failure); 20-40 hours/month manual compliance per facility
- Frequency: Ongoing since Dec 2022; full enforcement by April 2025
- Root Cause: Manual serialization, aggregation, and reporting without integrated software
Why This Matters
This pain point represents a significant opportunity for B2B solutions targeting Wholesale Drugs and Sundries.
Affected Stakeholders
Marketing Authorization Holders (MAHs), Licensed Agents/Distributors, 3PL Providers
Action Plan
Run AI-powered research on this problem. Each action generates a detailed report with sources.
Methodology & Sources
Data collected via OSINT from regulatory filings, industry audits, and verified case studies.
Related Business Risks
فقدان القدرة بسبب التجميع اليدوي
10-20% capacity loss (AED 100,000+ monthly for mid-size wholesaler); 30-50 hours/week manual aggregation labor
تكاليف زائدة للالتزام بتتمين
AED 150,000-500,000 initial setup (GLN, software, training); AED 20,000/month ongoing manual reporting
غرامات عدم الامتثال للـ VAT
AED 5,000-50,000 per violation; 2-5% revenue exposure from audit adjustments
مخاطر التسعير غير السليم للـ 340B
AED 50,000-500,000 annual inventory shrinkage (2-5% of drug stock); refund liabilities
تكاليف الامتثال الزائدة للـ 340B
40 hours/month manual tracking at AED 200/hour = AED 96,000/year
تسريب الخصومات الـ 340B
1-3% margin erosion (AED 100,000-500,000 for AED 50M turnover)